These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2606820)

  • 1. Efficacy of clavulanate-potentiated antibiotics against Bacteroides species and artificially associated cultures of aerobes and anaerobes.
    Werner H; Heizmann WR; Freuer G; Mitinis N; Heilmann F
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():55-61. PubMed ID: 2606820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM; Lamothe F
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
    Pierard D; De Meyer A; Rosseel P; Van Cauwenbergh M; Struelens MJ; Delmee M; Goossens H; Claeys G; Glupczynski Y; Verbist L; Melin P; Lauwers S
    Acta Clin Belg; 1996; 51(2):70-9. PubMed ID: 8693871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
    Jacobs MR; Spangler SK; Appelbaum PC
    Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
    Bansal MB; Chuah SK; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM; Tullio V; Paizis G; Carlone NA
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticarcillin/clavulanic acid: determination of minimal inhibitory concentrations against bacterial strains isolated from patients in intensive care units. Comparison with other agents.
    Pasargiklian I; Lusco G; Paizis G; Mascheroni E
    J Chemother; 1996 Apr; 8(2):113-21. PubMed ID: 8708742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G; Peters G; Kunstmann G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV; Aldridge KE
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.
    Rolinson GN
    J Chemother; 1994 Oct; 6(5):283-318. PubMed ID: 7861195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
    Roy C; Segura C; Torrellas A; Reig R; Teruel D; Hermida M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristic of clinical strains of gram-negative obligate anaerobes].
    Kadzielska J; Kierzkowska M; Sawicka-Grzelak A; Rokosz A; Łuczak M
    Med Dosw Mikrobiol; 2007; 59(4):351-7. PubMed ID: 18416127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.